Keyphrases
Prospective Cohort Study
84%
Elective Surgery
81%
International Cohort
61%
SARS-CoV-2 Infection
60%
Lung Ultrasound
52%
Noncardiac Surgery
52%
Vasoplegic Syndrome
52%
Postoperative Pulmonary Complications
52%
COVID-19
52%
After Surgery
51%
B-lines
41%
High-income Countries
39%
Surgical Patients
38%
Liver Transplantation
32%
Tranexamic Acid
31%
Randomized Controlled Trial
30%
Venous Thromboembolism
29%
Hypertension
29%
Hypotension
29%
Avoidance Strategy
29%
Brachial Plexus Block
26%
Number Needed to Vaccinate
26%
Preparedness Index
26%
Systems Strengthening
26%
Lung Effects
26%
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
26%
Brain-dead Donor
26%
Low-income Countries
26%
Impact of Surgery
26%
Low-middle Income Countries
26%
Controlled Donation after Circulatory Death
26%
Operative
26%
Middle-income Countries
26%
Donation after Circulatory Death
26%
Normothermic
26%
Transfusion
26%
Graft Survival
26%
Levobupivacaine
26%
SARS-CoV-2 Vaccination
26%
Ropivacaine
26%
Safe Surgery
26%
Environmental Impact
26%
Timing of Surgery
26%
Life Data
26%
Healthcare Workers
26%
Acute Kidney Injury
26%
Kidney Disease Improving Global Outcomes
26%
Ultrasound Abnormalities
26%
Twin Pregnancy
26%
Cardiopulmonary Bypass
26%
Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Prospective Cohort Study
84%
Infection
78%
Elective Surgery
70%
Noncardiac Surgery
52%
Lung
52%
Vasoplegia
52%
COVID-19
47%
Liver Transplantation
43%
Low and Middle Income Countries
31%
General Anesthesia
31%
Hemodynamic
31%
Tranexamic Acid
30%
Randomized Controlled Trial
30%
Hypotension
29%
Venous Thromboembolism
29%
Liver Graft
29%
Population
28%
Levobupivacaine
26%
Graft Survival
26%
Pulmonary Pathology
26%
Ropivacaine
26%
Brachial Plexus Block
26%
Lung Compliance
26%
Brain Death
26%
COVID-19 Vaccination
26%
Systematic Review
26%
Twin Pregnancy
26%
Nephropathy
26%
Cardiopulmonary Bypass
26%
Acute Kidney Injury
26%
Malignant Neoplasm
26%
Superior Vena Cava Syndrome
26%
Heart Pacing
26%
Drug Therapy
25%
Clinician
23%
Antihypertensive Agent
21%
Regional Perfusion
21%
Anesthesiologist
21%
Placebo
20%
Bleeding
19%
Consultation
18%
Hazard Ratio
14%
Cardiovascular System
13%
Anesthetic Gas
13%
Antiplatelet Drug
13%
Cancer
13%
Hematoma
13%
Laceration
13%
Echocardiography
13%